AAPL303.12-30.31 (-9.09%) ▼|ABBV252.00-5.42 (-2.10%) ▼|ABT104.52-1.09 (-1.03%) ▼|ACN162.00-1.29 (-0.79%) ▼|ADBE243.69-4.21 (-1.70%) ▼|AMAT518.03+16.26 (+3.24%) ▲|AMD492.51+7.12 (+1.47%) ▲|AMGN382.14-5.50 (-1.42%) ▼|AMT171.62-2.85 (-1.63%) ▼|AMZN269.84+34.34 (+14.58%) ▲|AVGO382.83-5.01 (-1.29%) ▼|AXP337.24-0.28 (-0.08%) ▼|BA213.80-7.10 (-3.21%) ▼|BAC61.89+0.16 (+0.25%) ▲|BKNG193.11-0.13 (-0.07%) ▼|BLK1,095.18-3.20 (-0.29%) ▼|BMY64.17-0.69 (-1.06%) ▼|BNY156.40+0.32 (+0.21%) ▲|BRK-B509.00-0.68 (-0.13%) ▼|C132.91+0.59 (+0.45%) ▲|CAT815.88+6.74 (+0.83%) ▲|CL90.87-0.74 (-0.80%) ▼|CMCSA23.76+0.09 (+0.38%) ▲|COF208.31-1.83 (-0.87%) ▼|COP118.48-0.55 (-0.46%) ▼|COST948.28-5.89 (-0.62%) ▼|CRM180.42-0.29 (-0.16%) ▼|CSCO114.38+0.82 (+0.72%) ▲|CVS105.14-0.08 (-0.08%) ▼|CVX192.53+0.22 (+0.11%) ▲|DE594.35-5.12 (-0.85%) ▼|DHR193.94-2.24 (-1.14%) ▼|DIS96.13-0.03 (-0.03%) ▼|DUK126.01-0.27 (-0.21%) ▼|EMR148.98+0.34 (+0.23%) ▲|FDX308.43-0.13 (-0.04%) ▼|GD378.37-3.83 (-1.00%) ▼|GE357.34+2.30 (+0.65%) ▲|GEV993.42+11.44 (+1.17%) ▲|GILD129.60-1.69 (-1.28%) ▼|GM87.92-0.48 (-0.54%) ▼|GOOG347.05+13.37 (+4.01%) ▲|GOOGL347.51+13.85 (+4.15%) ▲|GS1,019.69-5.18 (-0.50%) ▼|HD330.22-3.13 (-0.94%) ▼|HON240.44-1.47 (-0.61%) ▼|IBM217.26-4.48 (-2.02%) ▼|INTC93.30+2.17 (+2.38%) ▲|INTU311.89-3.61 (-1.14%) ▼|ISRG350.70-2.27 (-0.64%) ▼|JNJ254.72-1.10 (-0.43%) ▼|JPM352.06+1.21 (+0.34%) ▲|KO87.68-0.81 (-0.92%) ▼|LIN478.23-30.41 (-5.98%) ▼|LLY1,125.96-29.02 (-2.51%) ▼|LMT572.71-1.40 (-0.24%) ▼|LOW208.04-2.04 (-0.97%) ▼|LRCX303.18+5.46 (+1.83%) ▲|MA568.75-8.60 (-1.49%) ▼|MCD268.44+0.00 (+0.00%) ▲|MDLZ62.78-0.30 (-0.48%) ▼|MDT84.24-1.48 (-1.72%) ▼|META546.68+7.65 (+1.42%) ▲|MMM175.40-0.67 (-0.38%) ▼|MO69.08+1.14 (+1.67%) ▲|MRK129.74-0.06 (-0.04%) ▼|MS210.96+2.05 (+0.98%) ▲|MSFT452.86+1.76 (+0.39%) ▲|MU851.13-23.53 (-2.69%) ▼|NEE87.73-0.20 (-0.23%) ▼|NFLX71.35-1.82 (-2.49%) ▼|NKE41.76-0.53 (-1.25%) ▼|NOW108.83-1.24 (-1.13%) ▼|NVDA197.00+1.96 (+1.00%) ▲|ORCL126.83-0.73 (-0.57%) ▼|PEP139.28-0.93 (-0.66%) ▼|PFE24.86-0.06 (-0.22%) ▼|PG142.54-1.42 (-0.99%) ▼|PLTR120.47-1.79 (-1.46%) ▼|PM191.84-0.16 (-0.08%) ▼|QCOM148.67-2.94 (-1.94%) ▼|RTX212.96-1.42 (-0.66%) ▼|SBUX105.09-0.76 (-0.72%) ▼|SCHW104.58+0.25 (+0.24%) ▲|SO94.70+0.36 (+0.38%) ▲|SPG230.40-0.04 (-0.02%) ▼|T23.44+0.23 (+0.97%) ▲|TMO566.39-10.38 (-1.80%) ▼|TMUS170.71-2.63 (-1.52%) ▼|TSLA304.78-4.07 (-1.32%) ▼|TXN276.92-1.84 (-0.66%) ▼|UBER69.67-0.71 (-1.00%) ▼|UNH417.25-4.23 (-1.00%) ▼|UNP290.90+1.44 (+0.50%) ▲|UPS104.45-0.82 (-0.78%) ▼|USB62.76-0.14 (-0.22%) ▼|V364.16-2.11 (-0.58%) ▼|VZ46.31+0.20 (+0.42%) ▲|WFC85.79+0.36 (+0.42%) ▲|WMT111.12+0.02 (+0.02%) ▲|XOM153.05-3.92 (-2.50%) ▼|AAPL303.12-30.31 (-9.09%) ▼|ABBV252.00-5.42 (-2.10%) ▼|ABT104.52-1.09 (-1.03%) ▼|ACN162.00-1.29 (-0.79%) ▼|ADBE243.69-4.21 (-1.70%) ▼|AMAT518.03+16.26 (+3.24%) ▲|AMD492.51+7.12 (+1.47%) ▲|AMGN382.14-5.50 (-1.42%) ▼|AMT171.62-2.85 (-1.63%) ▼|AMZN269.84+34.34 (+14.58%) ▲|AVGO382.83-5.01 (-1.29%) ▼|AXP337.24-0.28 (-0.08%) ▼|BA213.80-7.10 (-3.21%) ▼|BAC61.89+0.16 (+0.25%) ▲|BKNG193.11-0.13 (-0.07%) ▼|BLK1,095.18-3.20 (-0.29%) ▼|BMY64.17-0.69 (-1.06%) ▼|BNY156.40+0.32 (+0.21%) ▲|BRK-B509.00-0.68 (-0.13%) ▼|C132.91+0.59 (+0.45%) ▲|CAT815.88+6.74 (+0.83%) ▲|CL90.87-0.74 (-0.80%) ▼|CMCSA23.76+0.09 (+0.38%) ▲|COF208.31-1.83 (-0.87%) ▼|COP118.48-0.55 (-0.46%) ▼|COST948.28-5.89 (-0.62%) ▼|CRM180.42-0.29 (-0.16%) ▼|CSCO114.38+0.82 (+0.72%) ▲|CVS105.14-0.08 (-0.08%) ▼|CVX192.53+0.22 (+0.11%) ▲|DE594.35-5.12 (-0.85%) ▼|DHR193.94-2.24 (-1.14%) ▼|DIS96.13-0.03 (-0.03%) ▼|DUK126.01-0.27 (-0.21%) ▼|EMR148.98+0.34 (+0.23%) ▲|FDX308.43-0.13 (-0.04%) ▼|GD378.37-3.83 (-1.00%) ▼|GE357.34+2.30 (+0.65%) ▲|GEV993.42+11.44 (+1.17%) ▲|GILD129.60-1.69 (-1.28%) ▼|GM87.92-0.48 (-0.54%) ▼|GOOG347.05+13.37 (+4.01%) ▲|GOOGL347.51+13.85 (+4.15%) ▲|GS1,019.69-5.18 (-0.50%) ▼|HD330.22-3.13 (-0.94%) ▼|HON240.44-1.47 (-0.61%) ▼|IBM217.26-4.48 (-2.02%) ▼|INTC93.30+2.17 (+2.38%) ▲|INTU311.89-3.61 (-1.14%) ▼|ISRG350.70-2.27 (-0.64%) ▼|JNJ254.72-1.10 (-0.43%) ▼|JPM352.06+1.21 (+0.34%) ▲|KO87.68-0.81 (-0.92%) ▼|LIN478.23-30.41 (-5.98%) ▼|LLY1,125.96-29.02 (-2.51%) ▼|LMT572.71-1.40 (-0.24%) ▼|LOW208.04-2.04 (-0.97%) ▼|LRCX303.18+5.46 (+1.83%) ▲|MA568.75-8.60 (-1.49%) ▼|MCD268.44+0.00 (+0.00%) ▲|MDLZ62.78-0.30 (-0.48%) ▼|MDT84.24-1.48 (-1.72%) ▼|META546.68+7.65 (+1.42%) ▲|MMM175.40-0.67 (-0.38%) ▼|MO69.08+1.14 (+1.67%) ▲|MRK129.74-0.06 (-0.04%) ▼|MS210.96+2.05 (+0.98%) ▲|MSFT452.86+1.76 (+0.39%) ▲|MU851.13-23.53 (-2.69%) ▼|NEE87.73-0.20 (-0.23%) ▼|NFLX71.35-1.82 (-2.49%) ▼|NKE41.76-0.53 (-1.25%) ▼|NOW108.83-1.24 (-1.13%) ▼|NVDA197.00+1.96 (+1.00%) ▲|ORCL126.83-0.73 (-0.57%) ▼|PEP139.28-0.93 (-0.66%) ▼|PFE24.86-0.06 (-0.22%) ▼|PG142.54-1.42 (-0.99%) ▼|PLTR120.47-1.79 (-1.46%) ▼|PM191.84-0.16 (-0.08%) ▼|QCOM148.67-2.94 (-1.94%) ▼|RTX212.96-1.42 (-0.66%) ▼|SBUX105.09-0.76 (-0.72%) ▼|SCHW104.58+0.25 (+0.24%) ▲|SO94.70+0.36 (+0.38%) ▲|SPG230.40-0.04 (-0.02%) ▼|T23.44+0.23 (+0.97%) ▲|TMO566.39-10.38 (-1.80%) ▼|TMUS170.71-2.63 (-1.52%) ▼|TSLA304.78-4.07 (-1.32%) ▼|TXN276.92-1.84 (-0.66%) ▼|UBER69.67-0.71 (-1.00%) ▼|UNH417.25-4.23 (-1.00%) ▼|UNP290.90+1.44 (+0.50%) ▲|UPS104.45-0.82 (-0.78%) ▼|USB62.76-0.14 (-0.22%) ▼|V364.16-2.11 (-0.58%) ▼|VZ46.31+0.20 (+0.42%) ▲|WFC85.79+0.36 (+0.42%) ▲|WMT111.12+0.02 (+0.02%) ▲|XOM153.05-3.92 (-2.50%) ▼|
27.1 C
New York
Friday, July 31, 2026

Tag: oral

newssourceFORcompanyinformationcontent1releasesmarket

2026 ASCO LBA | Juncell Therapeutics’ GC101 TIL Therapy Achieves Primary Endpoint in the Pivotal Phase II Trial for PD-1 Antibody Failed Advanced Melanoma

SHANGHAI, June 3, 2026 /PRNewswire/ -- On June 1 (Chicago time), in a Late-Breaking Abstract (LBA) oral presentation at the 2026 American Society of Clinical...

Transcontinental Inc. Announces Results for the Second Quarter of Fiscal Year 2026

Résultats pour le deuxième trimestre 2026

Globaltech Corp. (OTCQB: GLTK) Update to Shareholders

RENO, Nevada, June 03, 2026 (GLOBE NEWSWIRE) -- Globaltech Corporation (“Globaltech” or the “Company”) (OTCQB: GLTK), a U.S.-based technology holding company, is providing this Update to Shareholders to discuss: (i) how we are managing and operating the Company day to day, (ii) our near-term priorities with a long-term orientation, and (iii) how we responsibly and methodically approach innovation, including AI-enabled products and services.

Persist AI Teams up with Microsize and Micromacinazione (Micmac) to Launch First-of-Its-Kind Early-Stage “Micromill” Formulation Platform, Enabling Drug Development Decision With Milligrams of API

New collaboration delivers a fully integrated formulation workflow from early solubility studies to high-throughput dissolution, stability, and in-process analytics, making drug formulation less artisanal...

MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2 Trial...

MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2

Levicept to Present Data Suggesting LEVI-04 May Modify Disease in Osteoarthritis at EULAR 2026

Further clinical efficacy and pharmacology data also to be presented 
Further clinical efficacy and pharmacology data also to be presented

Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care

Novo Nordisk is launching Wegovy® pill in the UAE, the first country outside the US, to make the Wegovy® pill available to people living with obesity

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and...

Antengene to Present First Preclinical Data on ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at EULAR 2026

SHANGHAI and HONG KONG, June 3, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated...

ASCO 2026 | Updated Data from an Oral Presentation of InnoCare’s Novel BCL2 Inhibitor Mesutoclax in MDS and AML Released

InnoCare's novel BCL2i mesutoclax in MDS and AML was released at 2026 ASCO as an oral presentation, demonstrating outstanding efficacy and safety.

Kelun-Biotech Presents First-in-human Study Data for Its Novel B7-H3 ADC SKB500 at ASCO 2026

CHENGDU, China, June 3, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that at the 2026 American Society...

DBV Technologies annonce le screening du premier participant de l’étude clinique de phase 2 THRIVE pour le patch VIASKIN® Peanut chez les nourrissons âgés...

Châtillon, France, le 02 juin (22 :30 CEST) 2026

Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026...

- The INDIGO study met its primary and all key secondary endpoints with statistically significant results -

Demand for Compounding Pharmacies in USA to Reach USD 12.79 Billion by 2036 Amid Growing Need for Personalized Therapies and Specialized Medication Solutions

NEWARK, Del., June 2, 2026 /PRNewswire/ -- The Demand for Compounding Pharmacies in USA is projected to grow from USD 6.04 billion in 2026 to...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsOral

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers